Skip to main content
May 23, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Jakafi
Myeloproliferative Neoplasms
Myeloproliferative Neoplasm Update ASH 2021
By Dr. C.H. Weaver M.D.
Dec 16, 2021
Treatment & Care
Understanding GVHD and its Management
By Dr. C.H. Weaver M.D.
Dec 24, 2021
Myeloproliferative Neoplasms Survivorship
Study suggests Jakafi not associated with increase in significant secondary malignancies.
By Dr. C.H. Weaver M.D.
Mar 29, 2022
Myeloproliferative Neoplasms Treatment
Navitoclax-Jakafi combo being evaluated in myelofibrosis
By Dr. C.H. Weaver M.D.
Apr 18, 2022
Myeloproliferative Neoplasms Treatment
Overview of Polycythemia Vera
By Dr. C.H. Weaver M.D.
Mar 29, 2022
Myeloproliferative Neoplasms Treatment
Imetelstat for Myelofibrosis
By Dr. C.H. Weaver M.D.
Aug 13, 2021
Myeloproliferative Neoplasms Treatment
Interferon in The Management of PV and ET
By Dr. C.H. Weaver M.D.
Nov 14, 2021
Myeloproliferative Neoplasms Survivorship
Diagnosed with an MPN? Consider a Second Opinion and See an Expert!
By Dr. C.H. Weaver M.D.
Aug 19, 2021
Myeloproliferative Neoplasms Overviews
Overview of Myeloproliferative Neoplasms
By Dr. C.H. Weaver M.D.
Apr 29, 2021
Myeloproliferative Neoplasms Treatment
Jakafi Superior to Standard Therapy for Polycythemia Vera
By Dr. C.H. Weaver M.D.
Sep 11, 2021
Myeloproliferative Neoplasms Overviews
Treatment of Myelofibrosis
By Dr. C.H. Weaver M.D.
May 6, 2022
Myeloproliferative Neoplasms Treatment
Inrebic (fedratinib) Treatment of Myelofibrosis
By Dr. C.H. Weaver M.D.
Aug 14, 2021
CLOSE
CLOSE
CLOSE
CLOSE